|
UNITED STATES |
||||
|
[X] |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|||
|
For Quarterly period ended SEPTEMBER 30, 2004 |
||||
|
[ ] |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|||
|
Commission File No. 0-13888 |
||||
|
CHEMUNG FINANCIAL CORPORATION |
||||
|
(Exact name of registrant as specified in its charter) |
||||
|
New York |
16-1237038 |
|||
|
(State or other jurisdiction of incorporation or organization) |
I.R.S. Employer Identification No. |
|||
|
One Chemung Canal Plaza, Elmira, NY |
14901 |
|||
|
(Address of principal executive offices) |
(Zip Code) |
|||
|
(607) 737-3711 or (800) 836-3711 |
||||
|
(Registrant's telephone number, including area code) |
||||
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES: XX NO: |
||||
|
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act.) |
||||
|
YES XX NO |
||||
|
The number of shares of the registrant's common stock, $.01 par value, outstanding on October 29, 2004 was 3,667,264 |
||||
CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARIES
INDEX
|
PART I. |
FINANCIAL INFORMATION |
PAGE |
|
Item 1: |
Financial Statements - Unaudited |
|
| Consolidated Balance Sheets |
1 |
|
| Consolidated Statements of Income |
2 |
|
| Consolidated Statements of Shareholders' Equity and Comprehensive Income |
|
|
| Consolidated Statements of Cash Flows |
4 |
|
| Notes to Unaudited Consolidated Financial Statements |
|
|
|
Item 2: |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
|
|
Item 3: |
Quantitative and Qualitative Disclosures about Market Risk |
|
|
Item 4: |
Controls and Procedures |
21 |
|
PART II. |
OTHER INFORMATION |
22 |
|
Item 2: |
Unregistered Sales of Equity Securities and Use of Proceeds |
|
|
Item 6: |
Exhibits |
22 |
|
SIGNATURES |
23 |
Item 1: Financial Statements
CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
|
SEPTEMBER 30, |
DECEMBER 31, |
|
|
ASSETS |
||
|
Cash and due from banks |
$ 25,299,156 |
24,985,636 |
|
Federal funds sold |
- |
12,400,000 |
|
Interest-bearing deposits with other financial |
|
|
|
Total cash and cash equivalents |
26,235,886 |
38,069,778 |
|
Securities available for sale, at estimated fair value |
281,313,033 |
282,920,294 |
|
Securities held to maturity, estimated fair value of |
15,351,400 |
|
|
Loans, net of deferred origination fees and costs, and unearned income |
378,326,901 |
|
|
Allowance for loan losses |
(9,769,293) |
(9,848,259) |
|
Loans, net |
368,557,608 |
380,504,987 |
|
Loans held for sale |
11,006,690 |
- |
|
Premises and equipment, net |
16,996,844 |
17,471,607 |
|
Goodwill |
1,516,666 |
1,516,666 |
|
Other intangible assets, net |
1,856,025 |
2,154,315 |
|
Other assets |
11,344,941 |
11,487,546 |
|
|
||
|
Total assets |
$ 734,179,093 |
747,209,483 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
||
|
Deposits: |
||
|
Non-interest-bearing |
$ 118,221,161 |
122,363,563 |
|
Interest-bearing |
409,005,932 |
428,687,764 |
|
Total deposits |
527,227,093 |
551,051,327 |
|
Securities sold under agreements to repurchase |
90,063,236 |
79,034,796 |
|
Federal Home Loan Bank advances |
25,000,000 |
25,000,000 |
|
Accrued interest payable |
1,100,254 |
1,124,186 |
|
Dividends payable |
846,590 |
859,415 |
|
Other liabilities |
7,793,829 |
10,146,887 |
|
Total liabilities |
652,031,002 |
667,216,611 |
|
Shareholders' equity: |
||
|
Common stock, $.01 par value per share, 10,000,000 |
43,001 |
|
|
Capital surplus |
22,616,743 |
22,506,573 |
|
Retained earnings |
68,417,790 |
64,750,787 |
|
Treasury stock, at cost (619,310 shares at September 30, 2004; 563,546 shares at December 31, 2003) |
(14,776,960) |
(13,071,791) |
|
Accumulated other comprehensive income |
5,847,517 |
5,764,302 |
|
Total shareholders' equity |
82,148,091 |
79,992,872 |
|
Total liabilities and shareholders' equity |
$ 734,179,093 |
747,209,483 |
|
See accompanying notes to unaudited consolidated financial statements. |
||
CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
|
Nine Months Ended |
Three Months Ended |
|||
|
INTEREST AND DIVIDEND INCOME |
||||
|
2004 |
2003 |
2004 |
2003 |
|
|
Loans |
$17,887,014 |
$20,902,879 |
5,967,297 |
6,686,454 |
|
Securities |
9,328,376 |
8,198,044 |
3,088,046 |
2,746,758 |
|
Federal funds sold |
101,940 |
197,085 |
16,055 |
43,482 |
|
Interest-bearing deposits |
3,914 |
8,609 |
1,358 |
3,066 |
|
Total interest and dividend income |
27,321,244 |
29,306,617 |
9,072,756 |
9,479,760 |
|
INTEREST EXPENSE |
||||
|
Deposits |
4,909,783 |
6,540,999 |
1,573,564 |
1,918,444 |
|
Borrowed funds |
824,889 |
826,419 |
279,944 |
276,402 |
|
Securities sold under agreements to repurchase |
|
|
|
|
|
Total interest expense |
8,212,708 |
9,930,787 |
2,691,662 |
3,007,920 |
|
Net interest income |
19,108,536 |
19,375,830 |
6,381,094 |
6,471,840 |
|
Provision for loan losses |
1,166,667 |
4,350,000 |
333,334 |
2,150,000 |
|
Net interest income after provision for loan losses |
|
|
|
|
|
Other operating income: |
||||
|
Trust & investment services income |
3,510,614 |
|
1,131,821 |
|
|
Service charges on deposit accounts |
3,187,290 |
|
|
|
|
Net gain on securities transactions |
218,961 |
1,184,777 |
- |
234,777 |
|
Credit card merchant earnings |
1,015,453 |
894,177 |
384,171 |
338,972 |
|
Other |
1,867,520 |
1,752,243 |
514,829 |
643,783 |
|
Total other operating income |
9,799,838 |
10,022,436 |
3,094,966 |
3,422,251 |
|
Other operating expenses: |
||||
|
Salaries & wages |
6,961,738 |
7,222,213 |
2,368,725 |
2,444,948 |
|
Pension and other employee benefits |
2,150,322 |
2,179,279 |
623,997 |
734,009 |
|
Net occupancy expenses |
1,712,358 |
1,572,232 |
556,876 |
524,077 |
|
Furniture and equipment expenses |
1,418,088 |
1,405,627 |
447,899 |
468,549 |
|
Amortization of intangible assets |
298,290 |
298,290 |
99,430 |
99,430 |
|
Other |
6,337,456 |
6,362,331 |
2,099,926 |
2,224,038 |
|
Total other operating expenses |
18,878,252 |
19,039,972 |
6,196,853 |
6,495,051 |
|
Income before income tax expense |
8,863,455 |
6,008,294 |
2,945,873 |
1,249,040 |
|
Income tax expense |
2,641,104 |
1,589,903 |
899,411 |
273,674 |
|
Net income |
$ 6,222,351 |
$ 4,418,391 |
2,046,462 |
975,366 |
|
Weighted average shares outstanding |
3,782,663 |
3,824,916 |
3,766,599 |
3,812,037 |
|
Basic and diluted earnings per share |
$1.64 |
$1.16 |
$0.54 |
$0.26 |
See accompanying notes to unaudited consolidated financial statements.
CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME
(UNAUDITED)
|
|
|
|
|
Accumulated Other Comprehensive Income |
|
|
|
Balances at December 31, 2002 |
$ 43,001 |
$22,355,407 |
$61,247,551 |
$(11,826,290)) |
$ 7,607,508 |
$79,427,177 |
|
Comprehensive Income: |
||||||
|
Net income |
- |
- |
4,418,391 |
- |
- |
4,418,391 |
|
Other comprehensive loss |
- |
- |
- |
- |
(2,034,668) |
(2,034,668) |
|
Total comprehensive income |
2,383,723 |
|||||
|
Restricted stock units for directors' deferred compensation plan |
|
|
- |
- |
- |
119,183 |
|
Cash dividends declared ($.69 per share) |
|
|
|
|
|
|
|
Distribution of restricted stock units for directors' deferred compensation plan |
|
|
|
|
- |
|
|
Purchase of 39,148 shares of treasury stock |
|
|
|
|
|
|
|
Balances at September 30, 2003 |
$ 43,001 |
22,457,365 |
63,075,142 |
(12,978,302) |
5,572,840 |
78,170,046 |
|
Balances at December 31, 2003 |
$ 43,001 |
22,506,573 |
64,750,787 |
(13,071,791) |
5,764,302 |
79,992,872 |
|
Comprehensive Income: |
||||||
|
Net income |
- |
- |
6,222,351 |
- |
- |
6,222,351 |
|
Other comprehensive income |
- |
- |
- |
- |
83,215 |
83,215 |
|
Total comprehensive income |
6,305,566 |
|||||
|
Restricted stock units for directors' deferred compensation plan |
|
|
- |
- |
- |
110,170 |
|
Cash dividends declared ($.69 per share) |
|
|
|
|
|
|
|
Purchase of 55,764 shares of treasury stock |
|
|
|
|
|
|
|
Balances at September 30, 2004 |
$ 43,001 |
$22,616,743 |
$68,417,790 |
$(14,776,960)) |
$ 5,847,517 |
$82,148,091 |
CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
Nine Months Ended |
||
|
September 30 |
||
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
2004 |
2003 |
|
Net income |
$ 6,222,351 |
4,418,391 |
|
Adjustments to reconcile net income to net cash |
||
|
Amortization of intangible assets |
298,290 |
298,290 |
|
Provision for loan losses |
1,166,667 |
4,350,000 |
|
Depreciation and amortization |
1,675,306 |
1,649,895 |
|
Net amortization of premiums and discounts on securities |
353,090 |
1,275,407 |
|
Gain on sales of mortgage loans held for sale, net |
(28,045) |
(227,187) |
|
Proceeds from the sales of mortgage loans held for sale |
1,657,775 |
14,860,992 |
|
Mortgage loans originated and held for sale |
(1,764,230) |
(14,553,055) |
|
Net gain on securities transactions |
(218,961) |
(1,184,777) |
|
Decrease (increase) in other assets |
211,059 |
(382,097) |
|
Decrease in accrued interest payable |
(23,932) |
(264,951) |
|
Expense related to restricted stock units for directors' |
|
|
|
Decrease in other liabilities |
(406,150) |
(937,468) |
|
Net cash provided by operating activities |
9,253,390 |
9,422,623 |
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
||
|
Proceeds from sales of securities available for sale |
3,223,251 |
2,472,595 |
|
Proceeds from maturities of and principal collected on |
59,773,797 |
|
|
Proceeds from maturities of and principal collected on |
4,523,995 |
|
|
Purchases of securities available for sale |
(61,387,609) |
(151,326,325) |
|
Purchases of securities held to maturity |
(8,791,105) |
(5,001,097) |
|
Purchases of premises and equipment |
(1,200,543) |
(1,444,043) |
|
Net(increase)decrease in loans |
(2,020,364) |
24,329,963 |
|
Proceeds from sales of student loans |
1,860,432 |
6,448,382 |
|
Net cash used in investing activities |
(4,018,146) |
(4,193,410) |
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
||
|
Net (decrease) increase in demand deposits, NOW accounts, savings accounts, and insured money market accounts |
(13,437,984) |
|
|
Net decrease in time deposits and individual retirement accounts |
(10,386,250) |
(13,081,500) |
|
Net increase in securities sold under agreements to repurchase |
11,028,440 |
|
|
Repayments of Federal Home Loan Bank advances |
- |
(15,750,000) |
|
Purchase of treasury stock |
(1,705,169) |
(1,170,930) |
|
Cash dividends paid |
(2,568,173) |
(2,599,612) |
|
Net cash used in financing activities |
(17,069,136) |
(688,313) |
|
Net (decrease) increase in cash and cash equivalents |
(11,833,892) |
4,540,900 |
|
Cash and cash equivalents, beginning of period |
38,069,778 |
29,063,640 |
|
Cash and cash equivalents, end of period |
$26,235,886 |
33,604,540 |
|
Supplemental disclosure of cash flow information: |
||
|
Cash paid during the year for: |
||
|
Interest |
$ 8,236,641 |
10,195,738 |
|
Income Taxes |
$ 3,691,600 |
3,701,854 |
|
Supplemental disclosure of non-cash activity: |
||
|
Transfer of loans to other real estate owned |
$ 68,454 |
98,323 |
|
Adjustment of securities available for sale to fair value, net of tax |
|
|
|
Settlement of pending purchase of security |
$ 2,000,000 |
- |
|
See accompanying notes to unaudited consolidated financial statements. |
||
CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
Chemung Financial Corporation (the "Corporation"), through its wholly owned subsidiaries, Chemung Canal Trust Company (the "Bank") and CFS Group, Inc., a financial services company, provides a wide range of banking, financing, fiduciary and other financial services to its local market area. The consolidated financial statements include the accounts of the Corporation and its wholly owned subsidiaries. All material intercompany accounts and transactions are eliminated in consolidation.
The data in the consolidated balance sheet as of December 31, 2003 included in this Quarterly Report on Form 10-Q was derived from the audited consolidated financial statements in the Corporation's 2003 Annual Report on Form 10-K. That data, along with the other interim financial information presented in the consolidated balance sheets, statements of income, shareholders' equity and comprehensive income, and cash flows should be read in conjunction with the audited consolidated financial statements, including the notes thereto, contained in the 2003 Annual Report on Form 10-K. Amounts in prior periods' consolidated interim financial statements are reclassified whenever necessary to conform to the current period's presentation.
The consolidated financial statements included herein reflect all adjustments which are, in the opinion of management, of a normal recurring nature and necessary to present fairly the Corporation's financial position as of September 30, 2004 and December 31, 2003, and results of operations for the three and nine-month periods ended September 30, 2004 and 2003, and changes in shareholders' equity and cash flows for the nine-month periods ended September 30, 2004 and 2003. The results for the periods presented are not necessarily indicative of results to be expected for the entire fiscal year or any other interim period.
2. Earnings Per Share
Earnings per share were computed by dividing net income by 3,782,663 and 3,824,916 weighted average shares outstanding for the nine-month periods ended September 30, 2004 and 2003, respectively and 3,766,599 and 3,812,037 weighted average shares outstanding for the three-month periods ended September 30, 2004 and 2003, respectively. Issuable shares (such as those related to directors' restricted stock units) are considered outstanding and are included in the computation of basic earnings per share. There were no dilutive common stock equivalents during the three or nine-month periods ended September 30, 2004 or 2003.
3. Recent Accounting Pronouncements
In January 2003, the FASB issued FASB Interpretation No. 46 ("FIN No. 46"), "Consolidation of Variable Interest Entities, an interpretation of ARB No. 51." The objective of this interpretation is to provide guidance on how to identify a variable interest entity ("VIE") and determine when the assets, liabilities, noncontrolling interests, and results of operations of a VIE need to be included in a company's consolidated financial statements. A company that holds variable interests in an entity will need to consolidate the entity if the company's interest in the VIE is such that the company will absorb a majority of the VIE's expected losses and/or receive a majority of the entity's expected residual returns, if they occur. FIN No. 46 also requires additional disclosures by primary beneficiaries and other significant variable interest holders. FIN No.46 was effective for all VIE's created after January 31, 2003. However, the FASB had postponed that effective date to December 31, 2003. In December 2003, t
he FASB issued a revised FIN No. 46 ("FIN No. 46R"), which further delayed this effective date until March 31, 2004 for VIE's created prior to February 1, 2003, except for special purpose entities, which must adopt either FIN No. 46 or FIN No. 46R as of December 31, 2003. The Corporation does not have any special purpose entities, and the adoption of FIN No. 46 had no impact on the Corporation's consolidated financial statements at December 31, 2003. The adoption of FIN No. 46R at March 31, 2004 did not have a material impact on the Corporation's consolidated financial statements.
In March 2004, the FASB Emerging Issues Task Force ("EITF") reached a consensus on Issue 03-1, Meaning of Other Than Temporary Impairment (Issue 03-1). The Task Force reached a consensus on an other-than-temporary impairment model for debt and equity securities accounted for under SFAS No. 115, Accounting for Certain Investments in Debt and Equity Securities and cost method investments. The basic model developed by the Task Force in evaluating whether an investment within the scope of Issue 03-1 is other-than-temporarily impaired is as follows: Step 1: Determine whether an investment is impaired. An investment is considered impaired if its fair value is less than its cost. Step 2: Evaluate whether an impairment is other-than-temporary. For equity securities and debt securities that can contractually be prepaid or otherwise settled in such a way that the investor would not recover substantially all of its cost, an impairment is presumed to be other-than-temporary unless: the investor ha s the ability and intent to hold the investment for a reasonable period of time sufficient for a forecasted market price recovery of the investment, and evidence indicating that the cost of the investment is recoverable within a reasonable period of time outweighs evidence to the contrary. For other debt securities, an impairment is deemed other-than-temporary if: the investor does not have the ability and intent to hold the investment until a forecasted market price recovery (may mean until maturity), or it is probable that the investor will be unable to collect all amounts due according to the contractual terms of the debt security. Step 3: If the impairment is other-than-temporary, recognize in earnings an impairment loss equal to the difference between the investments cost and its fair value. The fair value of the investment then becomes the new cost basis of the investment and cannot be adjusted for subsequent recoveries in fair value, unless required by other authoritative literature.
On September 30, 2004, the FASB issued FSP EITF Issue 03-01-1, which delayed the effective date for the measurement and recognition guidance of an impairment loss that is other-than-temporary (i.e. steps 2 and 3 of the impairment model) contained in paragraphs 10-20 of EITF 03-1. Application of these paragraphs is deferred pending issuance of proposed FSP EITF Issue 03-1a. This delay does not suspend the requirement to recognize other-than-temporary impairments as required by existing authoritative literature. The guidance in paragraphs 6 to 9 of EITF 03-1 (i.e. steps of the impairment model), as well as the disclosure requirements in paragraphs 21 and 22 have not been deferred and should be applied based on the transition provisions in EITF 03-1. Based on the composition of the investment portfolio held at September 30, 2004, EITF 03-1 is not expected to have a material effect on the Company's financial position or results of operations.
The following table presents information relative to the Corporation's core deposit intangible ("CDI") related to the acquisition of deposits from the Resolution Trust Company in 1994:
|
At September 30, 2004 |
At December 31, 2003 |
|
|
Original core deposit intangible amount |
$ 5,965,793 |
$ 5,965,793 |
|
Less: Accumulated amortization |
4,109,768 |
3,811,478 |
|
Carrying amount |
$ 1,856,025 |
$ 2,154,315 |
Amortization expense for the nine months ended September 30, 2004 and 2003 related to the CDI was $298,290. As of September 30, 2004, the remaining amortization period for this CDI was approximately 4.5 years. The estimated amortization expense is $397,719 for each of the years ending December 31, 2004 through 2008, and $165,720 in aggregate amortization expense in subsequent years.
5. Comprehensive Income (Loss)
Comprehensive income or loss of the Corporation represents net income plus other comprehensive income or loss, which consists of the net change in unrealized holding gains or losses on securities available for sale, net of the related tax effect. Accumulated other comprehensive income or loss represents the net unrealized holding gains or losses on securities available for sale as of the consolidated balance sheet dates, net of the related tax effect.
Comprehensive income for the three and nine-month periods ended September 30, 2004 was $5,506,173 and $6,305,566, respectively. Comprehensive (loss) income for the three and nine-month periods ended September 30, 2003 was ($1,271,626) and $2,383,723, respectively. The following summarizes the components of other comprehensive income:
|
|
Three Months Ended |
|
|
2004 |
2003 |
|
|
Unrealized net holding gains (losses) on securities available for sale, net of tax (pre-tax amounts of $5,667,013 and ($3,445,800) for the respective periods indicated) |
|
|
|
Less: Reclassification adjustment for net gains realized in net income (pre- tax amounts of $0 and $234,777 for the respective periods indicated) |
|
|
|
Total other comprehensive income (loss) |
$ 3,459,711 |
(2,246,992) |
|
Nine Months Ended |
||
|
2004 |
2003 |
|
|
Unrealized net holding gains (losses) on securities available for sale, net of tax (pre-tax amounts of $355,268 and ($2,215,735) for the respective periods indicated) |
|
|
|
Less: Reclassification adjustment for net gains realized in net income (pre- tax amounts of $218,961 and $1,184,777 for the respective periods indicated) |
|
|
|
Total other comprehensive income (loss) |
$ 83,215 |
(2,034,668) |
6. Components of Quarterly and Annual Net Periodic Benefit Cost
|
Three Months Ended September 30, |
2004 |
2003 |
|
Qualified Pension |
||
|
Service cost, benefits earned during the period |
$ 111,455 |
176,852 |
|
Interest cost on projected benefit obligation |
280,531 |
388,850 |
|
Expected return on plan assets |
(359,784) |
(404,998) |
|
Net amortization and deferral |
33,430 |
74,197 |
|
Net periodic pension expense |
$ 65,632 |
234,901 |
|
Nine Months Ended September 30, |
2004 |
2003 |
|
Qualified Pension |
||
|
Service cost, benefits earned during the period |
$ 392,455 |
432,352 |
|
Interest cost on projected benefit obligation |
859,531 |
950,850 |
|
Expected return on plan assets |
(1,004,784) |
(982,998) |
|
Net amortization and deferral |
113,430 |
149,697 |
|
Net periodic pension expense |
$ 360,632 |
549,901 |
|
Three Months Ended September 30, |
2004 |
2003 |
|
Supplemental Pension |
||
|
Service cost, benefits earned during the period |
$ 3,130 |
3,476 |
|
Interest cost on projected benefit obligation |
10,216 |
11,189 |
|
Expected return on plan assets |
- |
- |
|
Net amortization and deferral |
7,959 |
24,815 |
|
Net periodic pension expense |
$ 21,305 |
39,480 |
|
Nine Months Ended September 30, |
2004 |
2003 |
|
Supplemental Pension |
||
|
Service cost, benefits earned during the period |
$ 9,392 |
10,426 |
|
Interest cost on projected benefit obligation |
30,648 |
33,565 |
|
Expected return on plan assets |
- |
- |
|
Net amortization and deferral |
23,875 |
36,805 |
|
Net periodic pension expense |
$ 63,915 |
80,796 |
|
Three Months Ended September 30, |
2004 |
2003 |
|
Postretirement, Medical and Life |
||
|
Service cost, benefits earned during the period |
$ 5,250 |
16,500 |
|
Interest cost on projected benefit obligation |
34,500 |
64,750 |
|
Expected return on plan assets |
- |
- |
|
Net amortization and deferral |
18,250 |
31,250 |
|
Net periodic expense |
$ 58,000 |
112,500 |
|
Nine Months Ended September 30, |
2004 |
2003 |
|
Postretirement, Medical and Life |
||
|
Service cost, benefits earned during the period |
$ 38,250 |
49,500 |
|
Interest cost on projected benefit obligation |
164,000 |
194,250 |
|
Expected return on plan assets |
- |
- |
|
Net amortization and deferral |
80,750 |
93,750 |
|
Net periodic expense |
$ 283,000 |
337,500 |
Postretirement Benefit Plans Other Than Pensions
On December 8, 2003 the Medicare Prescription Drug, Improvement and Modernization Act of 2003 ("Act") was enacted. The Act introduced a prescription drug benefit effective in 2006 under Medicare (Medicare Part D) as well as a federal subsidy commencing in 2006 to sponsors of retiree health care benefit plans that provide a benefit that is at least actuarially equivalent to Medicare Part D. The Corporation has determined that its prescription drug benefit will be actuarially equivalent to Medicare Part D in 2006 and will remain actuarially equivalent for approximately twenty-two years. Actuarial equivalency was determined based upon limited federal guidance. More in depth guidance is expected to be issued in 2005. The Corporation will remeasure the value of the expected federal subsidy payments once final guidance is issued to determine if any adjustments will be necessary.
Based on the Retroactive Application of FSP FAS 106-2, the January 1, 2004, Accumulated Postretirement Benefit Obligation decreases by $693,000 for recognition of the value of the future federal subsidy payments. The effect of the subsidy on the measurement of the 2004 net periodic postretirement benefit cost is as follows:
Reductions in Net Periodic Postretirement Benefit Cost
|
Quarter Ended September 30, 2004 |
Six Months Ended June 30, 2004 |
|
|
Service Cost |
$ (1,500) |
$ (3,000) |
|
Interest Cost |
(10,750) |
(21,500) |
|
Actuarial Gain |
(4,000) |
(8,000) |
|
Total |
$ (16,250) |
$ (32,500) |
The amount of net periodic postretirement benefit cost recognized for the quarter ended September 30, 2004 is as follows:
|
Service Cost |
$ 5,250 |
|
Interest Cost |
34,500 |
|
Amortization of Prior Service Cost |
28,250 |
|
Amortization of Gain |
(10,000) |
|
Total Net Periodic Postretirement Benefit Cost |
$ 58,000 |
Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations
The review that follows focuses on the significant factors affecting the financial condition and results of operations of Chemung Financial Corporation (the "Corporation") during the three and nine month periods ended September 30, 2004, with comparisons to the comparable periods in 2003, as applicable. The following discussion and the unaudited consolidated interim financial statements and related notes included in this report, should be read in conjunction with our 2003 Annual Report on Form 10-K. The results for the periods presented are not necessarily indicative of results to be expected for the entire fiscal year or any other interim period.
Forward-looking Statements
This Management's Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Corporation intends its forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in these sections. All statements regarding the Corporation's expected financial position and operating results, the Corporation's business strategy, the Corporation's financial plans, forecasted demographic and economic trends relating to the Corporation's industry and similar matters are forward-looking statements. These statements can sometimes be identified by our use of forward-looking words such as "may," "will," "anticipate," "estimate," "expect," or "intend." The Corporation cannot promise you that its expectations in such forward-looking statements will turn out to be correct. The Corporation's actual results could be materi
ally different from its expectations because of various factors, including credit risk, interest rate risk, competition, changes in the regulatory environment, and changes in general business and economic trends.
Critical Accounting Policies, Estimates and Risks and Uncertainties
Critical accounting policies include the areas where the Corporation has made what it considers to be particularly difficult, subjective or complex judgments in making estimates, and where these estimates can significantly affect the Corporation's financial results under different assumptions and conditions. The Corporation prepares its financial statements in conformity with accounting principles generally accepted in the United States. As a result, the Corporation is required to make certain estimates, judgements and assumptions that it believes are reasonable based upon the information available. These estimates, judgements and assumptions affect the reported amounts of assets and liabilities at the date of the financial statement and the reported amounts of revenue and expenses during the periods presented. Actual results could be different from these estimates.
Management considers the accounting policy relating to the allowance for loan losses to be a critical accounting policy given the inherent uncertainty in evaluating the level of the allowance required to cover probable credit losses inherent in the loan portfolio, and the material effect that such judgments can have on the Corporation's results of operations. While management's current evaluation of the allowance for loan losses indicates that the allowance is adequate, under adversely different conditions or assumptions, the allowance would need to be increased. For example, if historical loan loss experience significantly worsened or if current economic conditions significantly deteriorated, additional provisions for loan losses would be required to increase the allowance. In addition, the assumptions and estimates used in the internal reviews of the Corporation's non-performing loans and potential problem loans, and the associated evaluation of the related collateral coverage for these loans, has a sig
nificant impact on the overall analysis of the adequacy of the allowance for loan losses. While management has concluded that the current evaluation of collateral values is reasonable under the circumstances, if collateral evaluations were significantly lowered, the Corporation's allowance for loan losses policy would also require additional provisions for loan losses.
Total loans, net of unearned income and deferred fees and costs, decreased $12.0 million or 3.1% from December 31, 2003 to September 30, 2004. This decrease is primarily related to management's decision during the third quarter to sell the consumer credit card portfolio as well as certain non-performing and potential problem commercial loans. Accordingly, approximately $11.0 million of loans were reclassified during the quarter as held for sale. In regard to the consumer credit card portfolio, the Corporation entered into an agreement during the third quarter with TCM Bank, N.A. (TCM) to sell approximately $7.6 million in consumer credit card accounts. TCM specializes in credit card financing and administration. The decision to sell this portfolio was motivated by the increasing cost of processing and administration associated with the credit card portfolio, as well as TCM's ability to offer enhancements to our credit card holders. Following the sale, the Corporation, through a three-y ear participation agreement with TCM, will participate in the funding of 45.0% of the portfolio. This will provide the Corporation with ongoing revenue from the credit card portfolio, without the expense of processing and administration. We will also continue to offer credit cards under the Bank's name, acting as an agent for TCM. This sale will take place during the fourth quarter, and the Corporation expects to realize a total gain on the sale of this portfolio of approximately 16.5% of the amount sold.
As noted above, management also decided during the quarter to sell certain non-performing and potential problem commercial loans. Accordingly, during the quarter, these loans were written-down to the lower of cost or estimated fair value, which resulted in a charge to the allowance for loan losses of $772 thousand during the quarter. The carrying value of these loans, now classified as held for sale, totals $3.3 million. It is expected that these loans will be sold during the fourth quarter, and the Corporation does not anticipate this transaction to have a material impact on fourth quarter operating results. Aside from the impact of the above, loans were down $1.0 million since the beginning of the year. Approximately $5.2 million of this decrease was in commercial loans, including commercial mortgages, impacted in part by a $3.7 million decrease in floor plan balances. This decrease was primarily related to the sale of automobile dealerships during 2004 with whom we had a floor plan relationship. While mortgage activity has been fairly steady through the first nine months of 2004, total residential mortgages have decreased approximately $1.3 million since the end of 2003. In total, the consumer loan portfolio, excluding the transfer of consumer credit cards to held for sale, has grown $5.3 million during the first nine months of 2004, impacted primarily by increases in consumer installment and student loans of $2.1 million and $2.3 million, respectively. In addition to the above noted areas, home equity outstandings have increased $1.1 million since the beginning of the year.
The composition of the loan portfolio is summarized as follows:
|
September 30, 2004 |
December 31, 2003 |
|
|
Residential mortgages |
$ 85,989,161 |
$ 87,277,896 |
|
Commercial mortgages |
43,667,585 |
43,827,026 |
|
Commercial, financial and agricultural |
123,266,079 |
131,583,152 |
|
Consumer loans |
125,404,076 |
127,665,172 |
|
$378,326,901 |
$390,353,246 |
The available for sale segment of the securities portfolio totaled $281.3 million at September 30, 2004, compared to $282.9 million at the end of 2003, a decrease of approximately $1.6 million or 0.6%. Unrealized appreciation related to the available for sale portfolio has increased $136 thousand since the beginning of the year. At amortized cost, the available for sale portfolio was down $1.7 million since December 31, 2003. This decrease is primarily reflected in a $14.4 million decrease in mortgage-backed securities, offset primarily by a $13.6 million increase in federal agency bonds. During the first nine months of 2004, the Corporation purchased approximately $44.8 million of federal agency bonds, with approximately $28.2 million of federal agency bonds being called. Additionally, the Corporation sold a $3.0 million federal agency bond in March, realizing a pre-tax gain on the sale of $219 thousand. Although the Corporation has purchased approximately $15.0 million of mortgage-backed securities du
ring the first nine months of this year, this portfolio has declined due to the level of paydowns in the portfolio. The held to maturity segment of the portfolio, consisting primarily of local municipal obligations, totaled $15.4 million at amortized cost as of September 30, 2004, an increase of $2.3 million since December 31, 2003.
Deposits at September 30, 2004 totaled $527.2 million, a decrease of $23.8 million or 4.3% as compared to December 31, 2003. While period-end non-interest bearing demand deposits were down $4.1 million, most of the decrease in deposits was due to a $19.7 million reduction in interest bearing balances. This decrease in interest bearing balances was impacted primarily by lower insured money market, and time balances, offset to some extent by higher savings account balances. The decrease in interest bearing balances from December 31, 2003 to September 30, 2004 reflects the fact that in the absence of loan growth during the first nine months of 2004, the Corporation has not been aggressive in the pricing of these deposit products. The $11.0 million increase in securities sold under agreements to repurchase reflects an increase in security purchases leveraged with repurchase agreements through the Federal Home Loan Bank of New York.
Non-performing loans at September 30, 2004 totaled $10.957 million as compared to $12.331 million at December 31, 2003, a decrease of $1.374 million. Loans in non-accrual status have decreased $896 thousand. During the first nine months of 2004, two commercial relationships with a current balance of $450 thousand were added to the non-accrual category. These additions were offset primarily by principal reductions on other non-accruing commercial loans, as well as a reduced level of consumer loans in non-accrual status. Additionally, during the third quarter, the Corporation charged $228 thousand to the allowance for loan losses to write-down the balance of a non-accruing commercial relationship to its estimated fair value in conjunction with management's decision to sell these loans. A $277 thousand reduction in troubled debt restructurings resulted from the transfer of a relationship in this category at December 31, 2003 to non-accrual status during the second quarter of this year. Subsequent to this
transfer, $185 thousand of this credit was charged-off. The reduction in non-performing loans was also impacted by a $201 thousand decrease in accruing loans past due 90 days or more, this decrease related primarily to a decrease in residential mortgage loans in this category.
The following table summarizes the Corporation's non-performing assets:
|
(dollars in thousands) |
September 30, 2004 |